Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Researchers recommend limiting added sugar intake to 6 teaspoons daily
To prevent the adverse effects of added sugars, researchers recommend reducing intake to about 6 teaspoons per day and having less than one sugar-sweetened beverage every week.
CVD risk highest among adults with obesity and genetically predicted low BMI
Adults with a genetically predicted high BMI may have a lower risk for cardiovascular disease than those whose obesity is linked more to environmental factors, according to a study published in eClinicalMedicine.
Log in or Sign up for Free to view tailored content for your specialty!
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Weight regain does not erode cardiometabolic benefits of weight-loss programs
Participants in behavioral weight-loss programs improved several CV risk factors for at least 5 years after an intervention ended, despite weight regain, compared with low-intensity programs or controls, researchers reported.
GLP-1/glucagon dual agonist linked to 10% weight loss in half of adults with obesity
About half of adults taking a novel peptide-based GLP-1/glucagon dual receptor agonist in development for the treatment of obesity in nonalcoholic steatohepatitis lost 10% or more body weight at 24 weeks, according to a press release.
Steatosis present in most adults with type 1 diabetes and overweight or obesity
Hepatic steatosis may be present in most adults with type 1 diabetes, especially those with overweight or obesity, according to a study published in Journal of Diabetes and Its Complications.
FDA extends approval of evinacumab for HoFH to children aged 5 to 11 years
Regeneron Pharmaceuticals announced the FDA has extended approval of evinacumab-dgnb as an adjunct to other lipid-lowering therapy for the treatment of homozygous familial hypercholesterolemia in children aged 5 to 11 years.
Most patients at high CV risk are not achieving LDL goals
NEW ORLEANS — Most patients at high or very high CV risk do not achieve guideline-recommended LDL goals, according to data from the Family Heart Database presented at the American College of Cardiology Scientific Session.
Prevalence of metabolically healthy obesity increasing in US, but remains low overall
The percentage of adults with metabolically healthy obesity increased from 1999 to 2018 but remains much smaller than the proportion of those with metabolically unhealthy obesity, according to study data.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read